Evidence map›Paper›PMID 41545914›Full record

ArticleBMC infectious diseases2026

Adherence to hepatitis B vaccination recommendations for children and adolescents aged 3 to 17 years in Germany, 2014-2017: results from a cross-sectional national population-based study.

Sofie Gillesberg Lassen, Thomas Harder, Sandra Dudareva, Klaus Stark, Christina Poethko-Müller

Abstract read
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sofie Gillesberg LassenDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany. raisers@rki.de.
Thomas HarderDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany.
Sandra DudarevaDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany.
Klaus StarkDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany.
Christina Poethko-MüllerDepartment of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough universal childhood vaccination of hepatitis B has been recommended in Germany since 1995, evidence on adherence to the recommended hepatitis B vaccination schedule is lacking. Using data from the second wave of the population-based German Health Interview and Examination Survey for Children and Adolescents (KiGGS) (2014–2017), we aimed to assess the adherence to the recommended hepatitis B vaccination schedule by describing the timeliness of the first dose, the timeliness of the recommended vaccination series, the vaccination series by number of doses, and the adherence to six months period between the last two doses given.

methodsReflecting recommendations in Germany, we defined a timely first dose as given at two months of age or as a birth-dose given prior to two days of age. A catch-up vaccination series was defined as first dose given after 14 months of age. We defined a recommended hepatitis B vaccination series as at least three doses, with six months between the two last doses, as in accordance with national recommendations. We defined a hepatitis B vaccination series as being timely if the last dose was given prior to 15 months of age. We calculated weighted proportions and their 95% confidence intervals (CI) overall, according to socio-demographic and health utilization characteristics.

resultsOf the 3,165 included participants, 93.4% [95%CI: 91.9%-94.5%] received at least one hepatitis B vaccination dose; 48% [95%CI: 45%-51%] received a timely first dose and 4.62% [95%CI 3.59%–5.92%] received a catch-up vaccination series. Of all participants, 79.1% [95%CI: 76.8%-81.2%] received a recommended series, and 30.9% [95%CI: 28.3%-33.6%] had a timely recommended series. We found a higher proportion of children in birth-cohorts after 2001 with a timely first dose and a recommended series than children born in 1994–2001. The proportion of children with a timely first dose was higher for children living in eastern Germany (66.3%; 95%CI: 61.1%–71.2%) compared with western Germany (46.2%; 95%CI: 42.9%–49.6%).

conclusionsOur analyses reveal gaps in adherence to vaccination recommendations against hepatitis B in Germany. However, we identified great potential for catch-up vaccinations with close to 95% of children and adolescents receiving at least one hepatitis B vaccination dose.

Indexed as

Guideline AdherenceHepatitis BHepatitis B VaccinesVaccinationAdolescentChildChild, PreschoolCross-Sectional StudiesFemaleGermanyHumansImmunization ScheduleMaleHepatitis B VaccinesCross-sectional studyHepatitis BPopulation-basedTimelinesVaccination

Identifiers

PMID41545914
PMCPMC12849288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.